Alopecia areata (AA) is a common cause of hair loss,

Similar documents
Autoimmune Hair Loss (Alopecia Areata) Transferred by T Lymphocytes to Human Scalp Explants on SCID Mice

Alopecia areata (AA) is regarded as a nonscarring, in-

STUDY. Histopathologic Features of Alopecia Areata

Successful Treatment of Alopecia Areata-Like Hair Loss with the Contact Sensitizer Squaric Acid Dibutylester (SADBE) in C3H/HeJ Mice

What Are the Different Forms?

Alopecia areata (AA) is postulated to be an organ-speci c

Tips on getting the most from your alopecia pathology reports. D irector, H a ir C linic, Boston Medical C e n ter

Dr. Yi-chi M. Kong August 8, 2001 Benjamini. Ch. 19, Pgs Page 1 of 10 TRANSPLANTATION

Transplantation. Immunology Unit College of Medicine King Saud University

How to decipher a pathology report for alopecia

in alopeeia areata are not entirely defined. Sabouraud (1) made the fundamental observation

Snapshot Dx Quiz: September 2018 Detailed Answers

COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF

Autoimmunity & Transplantation. Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:

Efficacy of Topical Diphencyprone in the Treatment of Alopecia Areata

GENERAL OVERVIEW OF TYPES OF HAIR LOSS AND ALOPECIA TELOGEN EFFLUVIUM

Genetics of common disorders with complex inheritance Bettina Blaumeiser MD PhD

Hair growth stimulating effect of a nutrient mixture in athymic nude mice

22 year old QH mare with regionally extensive alopecia and scaling on one front limb and ventral chest (Figure 1 and 2).

The site of action of the ichthyosis locus (ic) in the mouse, as determined by dermal-epidermal recombinations

CHAPTER 22 Brocq s alopecia (pseudopelade of Brocq) and burnt out scarring alopecia

Treatment of alopecia universalis with topical Janus kinase inhibitors a double blind, placebo, and active controlled pilot study

MHC class I MHC class II Structure of MHC antigens:

SEVENTH EDITION CHAPTER

Lymphocytes, neuropeptides, and genes involved in alopecia areata

Significance of the MHC

Establishment of Patient-derived Xenografts in Mice.

Tolerance 2. Regulatory T cells; why tolerance fails. Abul K. Abbas UCSF. FOCiS

Central tolerance. Mechanisms of Immune Tolerance. Regulation of the T cell response

Mechanisms of Immune Tolerance

Observations on the Pathology of Lesions Associated with Stephanofilaria dinniki Round, 1964 from the Black Rhinoceros (Diceros bicornis)

What are bacteria? Microbes are microscopic(bacteria, viruses, prions, & some fungi etc.) How do the sizes of our cells, bacteria and viruses compare?

Spectrum of clinical presentations

Effect of Propecia on the Hair Follicle in Male Androgenetic Alopecia: A Confocal Laser Scanning Microscopy and Video Imaging Study

Immunology Lecture 4. Clinical Relevance of the Immune System

Supporting Information

Juyoun Jin, D.V.M., Ph.D. Institute for Refractory Cancer Research, Samsung Medical Center

Using the Ch6diak-Higashi Marker

cure research HIV & AIDS

Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza

Goals. Goals. From Bench to Cageside: Immunology of Humanizing Mice

From Bench to Cageside: Immunology of Humanizing Mice. Zachary T Freeman

Supplementary Materials. for Garmy-Susini, et al, Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis

Review Article Cytokines and Other Mediators in Alopecia Areata

ALOPECIA AREATA RESEARCH SUMMIT Forging the Future

Chapter 35 Active Reading Guide The Immune System

Diphencyprone (DCP) treatment

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

NOTES: CH 43, part 2 Immunity; Immune Disruptions ( )

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol

Immunology 2011 Lecture 11 Innate Immunity & Genetics of Inbreeding. 6 October

Interesting Case Series. Skin Grafting in Pyoderma Gangrenosum

The Lymphatic System and Body Defenses

PARASITOLOGY CASE HISTORY 10 (HISTOLOGY) (Lynne S. Garcia)

Alopecia areata (AA) is a common cause of hair loss. Characterization of Hair Follicle Antigens Targeted by the Anti-Hair Follicle Immune Response

Objectives. Abbas Chapter 11: Immunological Tolerance. Question 1. Question 2. Question 3. Definitions

Darwinian selection and Newtonian physics wrapped up in systems biology

A Novel Approach for Acne Treatment

IMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, psoriasis

Immunologically Induced and Elicited Local

Dermatopathology Workshop Summary, Berlin 2004

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

New Science Regrow Your Hair, Starting Now

Complete remission of alopecia universalis after allogeneic. hematopoetic stem cell transplantation.

Supporting Information

Trichofolliculoma of the Guinea Pig 1,2

KEY CONCEPT Germs cause many diseases in humans.

Thermal Dermal Burn Modeling in Rats and Minipigs

Supplementary Information

T cell development October 28, Dan Stetson

MOHS MICROGRAPHIC SURGERY: AN OVERVIEW

Differential Expression of CXCL1, CXCL9 CXCL10 and CXCL12 Chemokines in Alopecia Areata

Immunity and Cancer. Doriana Fruci. Lab di Immuno-Oncologia

Role of microenvironment and tumor interactions in melanoma progression with special regard to the prognostic significance of immune cell infiltrate

Immunology. Anas Abu-Humaidan M.D. Ph.D. Transplant immunology+ Secondary immune deficiency

Är diabetes mellitus en autoimmun sjukdom? Olle Korsgren

Daniel Asz Sigall, MD MEXICO

Oncolytic Immunotherapy: A Local and Systemic Antitumor Approach

Emerging Rodent Pathogens and Their Role in the Rodent Sentinel Program

IMO 3100, an antagonist of Toll like receptor (TLR) 7 and TLR9, demonstrates clinical activity in psoriasis patients

Case No. 5; Slide No. B13/8956/2

The Immune System: Innate and Adaptive Body Defenses Outline PART 1: INNATE DEFENSES 21.1 Surface barriers act as the first line of defense to keep

CD4+ T Helper T Cells, and their Cytokines in Immune Defense and Disease

HAEMATOPOIETIC STEM CELL TRANSPLANTATION

CATRIX WOUND DRESSING CARTILAGE POWDER

Topic (Final-03): Immunologic Tolerance and Autoimmunity-Part II

ALOPECIA AREATA RESEARCH SUMMIT Forging the Future

Case Report DOI: /ourd Georgia Dermatopathology Associates, Atlanta, Georgia, USA 2

The Innate Immune Response

Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell?

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

PRO-STIM Injectable Inductive Graft TECHNICAL MONOGRAPH

HYPER IgM SYNDROME This booklet is intended for use by patients and their families and should not replace advice from a clinical immunologist.

Harnessing tolerance mechanisms with monoclonal antibodies Prof. Herman Waldmann

Whisker growth induced by implantation of cultured vibrissa dermal papilla cells in the adult rat

ALOPECIA AREATA (AA) IS A

I. Lines of Defense Pathogen: Table 1: Types of Immune Mechanisms. Table 2: Innate Immunity: First Lines of Defense

Innate Immunity. Bởi: OpenStaxCollege

Medical Immunology Practice Questions-2016 Autoimmunity + Case Studies

Transcription:

Experimental Induction of Alopecia Areata-Like Hair Loss in C3H/HeJ Mice Using Full-Thickness Skin Grafts Kevin J. McElwee, Dawnalyn Boggess, Lloyd E. King Jr,* and John P. Sundberg The Jackson Laboratory, Bar Harbor, Maine, U.S.A.; *Division of Dermatology, Vanderbilt University, Nashville, Tennessee, U.S.A. Alopecia areata (AA)-like hair loss in C3H/HeJ mice provides an excellent model for human AA disease research. The potential to induce mouse AA in normal haired C3H/HeJ mice at an early age or serially passage the AA phenotype was investigated by exchange of fullthickness skin grafts. Skin grafts from normal male and female C3H/HeJ, or severe combined immunodeficient C3H/SmnC Prkdc scid /J, mice onto AA-affected C3H/HeJ mice became inflamed and lost hair (28 of 28). Successful grafts from AA-affected C3H/HeJ mice induced hair loss in histocompatible C3H/OuJ mice (four of 13) and normal C3H/HeJ mice dependent on age (four of 17 at <31 d and 15 of 15 at >70 d). The AA phenotype was serially transmitted from induced AA mice to normal C3H/HeJ mice (nine of nine). Grafts from AA-affected C3H/HeJ mice onto C3H/SmnC Prkdc scid /J mice resulted in depigmented hair fiber regrowth and perifollicular neutrophil and eosinophil infiltrates but no hair loss (15 of 15). Sham grafting did not induce AA (none of 10). The finding that AA can be serially transferred from AAaffected C3H/HeJ mice to normal littermates and C3H/ OuJ mice, indicates that an immune response against hair follicles can be induced with suitable stimuli. Conversely, skin grafts from normal C3H/HeJ, or C3H/SmnC Prkdc scid /J, mice rapidly lose hair due to lymphocyte, but not neutrophil and eosinophil, mediated inflammation. This AA induction method reproducibly provides large numbers of AA-affected mice to study the pathogenesis and treatment of human AA. Key words: adoptive transfer/ autoimmune disease/disease model/inflammation. J Invest Dermatol 111:797 803, 1998 Alopecia areata (AA) is a common cause of hair loss, afflicting almost 2% of the general population (Safavi et al, 1995). Evidence suggests that AA is an autoimmune disease with inflammatory cells, primarily lymphocytes, in and around dystrophic anagen hair follicles (Perret et al, 1984) and the production of autoantibodies specific for hair follicle antigens (Tobin et al, 1994). Although not life threatening, the disease can be so psychologically devastating for those affected that depression or suicide may occur (Colon et al, 1991; King, personal communication). Progress in understanding the pathogenesis and genetics of AA and developing new therapies has been hampered by the lack of an animal model for this disease. Recently, rat and mouse models, with phenotypic, histologic, and immunologic similarities to human AA, have been identified (Michie et al, 1991; Oliver et al, 1991; Sundberg et al, 1994b, 1995; Zhang and Oliver, 1994; McElwee et al, 1996, 1998b; McElwee and Oliver, 1997; Tobin et al, 1997). Aging C3H/HeJ mice develop a spontaneous, polygenic, semidominant, inflammatorybased, AA-like hair loss. Expression of hair loss rises to 20% in some colonies of mice 18 mo of age (Sundberg et al, 1994b). Initially, all C3H/HeJ mice produce a normal coat of agouti hair. The onset of disease typically develops as early as 4 mo of age in females with rapid, extensive progression. Males can be affected in equal numbers with similar patterns of balding, but the initial onset occurs at 6 12 mo of Manuscript received March 31, 1998; revised June 16, 1998; accepted for publication July 24, 1998. Reprint requests to: Dr. John P. Sundberg, The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609. Abbreviations: AA, alopecia areata; Prkdc scid or scid/scid, severe combined immune deficiency mouse mutation. age. Typically, alopecia initially develops on the ventral surface, expanding to cover the entire abdomen in a symmetrical pattern. Distinct foci of alopecia may develop elsewhere on the dorsal surface, bilaterally symmetrical or asymmetrical in appearance. Extensive hair loss, which may approach total body or universal alopecia, develops in 17% of AA-affected male and female mice. A diffuse type of AA can occasionally develop. Complete, spontaneous remission is recognized in up to 3% of affected mice (Sundberg et al, 1994b). This low incidence of alopecia with an unpredictable time of onset is typical of polygenic, multifactorial diseases in mice and not unlike that observed in humans. Such variable presentation, however, limits the experimental use of the C3H/HeJ model. In spontaneous C3H/HeJ mouse AA anagen hair follicles are affected by an intense peri-follicular inflammation of CD4 and CD8 lymphocytes in a ratio of 1:2, respectively. Some dendritic cells are also observed in the inflammation along with variable numbers of granulocytes. Peri-follicular inflammation is observed from the bulb to the sebaceous gland with the greatest infiltrate density observed around the infundibulum. Some T cells, primarily CD8 cells, penetrate to intrafollicular positions in the bulb and infundibulum. Long-term AAaffected mice show the same infiltrate distribution but with a reduced total number of inflammatory cells. Full-thickness skin grafts from humans to immunodeficient mice, such as those homozygous for nude (Hfh11 nu ) or severe combined immunodeficiency (Prkdc scid ), which accept xenografts, have been used to study a variety of cutaneous diseases including psoriasis (Kreuger et al, 1975, 1981; Haftek et al, 1981) and AA (Gilhar and Kreuger, 1987; Gilhar et al, 1992, 1998). An allograft approach can also be used between mice either to investigate the pathogenesis of a mutation with a cutaneous phenotype, as with flaky skin (fsn) and chronic proliferative dermatitis (cpdm), or to expand limited numbers of mice for testing 0022-202X/98/$10.50 Copyright 1998 by The Society for Investigative Dermatology, Inc. 797

798 McELWEE ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY studies when large production colonies are not available (Sundberg et al, 1994c; Gijbels et al, 1995). AA has successfully been induced by T cell transfer of in vitro stimulated human lymphocytes to human skin grafted onto severe combined immunodeficient Prkdc scid mice (Gilhar et al, 1998). AA-like hair loss has apparently been induced after melanoma immunotherapy in C57BL6/J mice (Becker et al, 1996), with the ability to transfer the phenotype to naïve mice by transfer of T cells. Cutaneous grafting experiments were done between C3H/HeJ mice with and without AA to determine the pathogenic effect on both the graft and the host. We showed for the first time that full-thickness AA-affected skin grafts onto histocompatible mice, yielded a cutaneous, nonscarring, inflammatory based hair loss (alopecia) with a predictable time course in recipients 70 d of age and older. MATERIALS AND METHODS Skin graft technique Donor mice were euthanized by CO 2 asphyxiation. Up to six grafts, µ1 1.5 cm in diameter, were aseptically removed from each donor by pinch cutting (Billingham and Medawar, 1951), four from the dorsal and two from the ventral surfaces of each mouse. The grafts were placed in sterile phosphate-buffered saline while the recipient mice were prepared. Recipient mice were anesthetized with tribromoethanol (0.2 ml per 10 g body weight; Aldrich, Milwaukee, WI). A circular piece of skin, µ1 1.5 cm in diameter, was aseptically removed from the dorsal anto-posterior midline of the recipient mouse and replaced with a donor skin graft. The graft was oriented 180 from normal in order to have the hair grow in the opposite direction to the recipient s hair for easy identification. Where possible recipient mice were given a combination of male and female donor-derived skin grafts; however, immunocompetent female recipient mice were only able to accept female donor derived skin grafts due to HY minor histocompatibility antigens. Four to six simple interrupted sutures (5-O Dexon S ; Davis & Geck, Manat, Puerto Rico) were placed at regular intervals around the edges of the graft. Nexaban (Veterinary Products Laboratory, Phoenix, AZ) was used on the opposing edges of the graft site to improve adherence. The grafts were then covered with a sterile Telfa pad (Kendall, Boston, MA), held in place with Micropore surgical tape (3M Medical-Surgical Division, St. Paul, MN), and further bandaged with Coban self-adherent wrap (3M Medical-Surgical Division). Wound clips were placed in the skin over the neck, pelvis, and thorax of each mouse to hold the bandages in place. Bandages were removed 4 6 d after the surgery. Mice were housed two or three per cage and all received autoclaved food pellets (NIH 31 modified with 6% fat, diet code 5K52, PMI, Richmond, IN) and acidified water ad libitum. Mice were given acidified water containing an antibiotic (Sulfamethoxazole & Trimethoprim Oral Suspension, USP, Schein Pharmaceutical, Florham, NJ) for three in every seven days for 2 wk after surgery to reduce the chance of infection. Immunodeficient C3H/SmnC Prkdc scid /J mice were also maintained indefinitely on the antibiotic acidified water 3 d per week to minimize complications with Pneumocystis carinii infection (Shultz et al, 1989). Skin graft studies All mice were supplied from stocks at The Jackson Laboratory (Bar Harbor, ME) specific pathogen-free production facility. In total, 111 skin graft recipient mice were analyzed in this study. Immunodeficient mice The C3H/SmnC Prkdc scid /J (hereafter referred to as C3H scid/scid) congenic strain has proved to be consistently immunodeficient and unable to produce functional T and B cells in response to antigenic challenge (Nonoyama et al, 1993). Skin from adult AA-affected male and female C3H/HeJ mice was grafted onto 15 female immunodeficient recipient C3H scid/scid mice with an age range of 50 81 d. Skin from C3H scid/scid female mice was also grafted onto 18 female AA-affected C3H/HeJ mice 209 294 d of age. Immunocompetent mice Skin from young unaffected C3H/HeJ mice was grafted onto 10 female, AA-affected C3H/HeJ mice with an age range of 331 359 days. To reciprocate, skin from AA-affected C3H/HeJ mice was grafted to 18 normal, adult C3H/HeJ mice (eight female, 10 male) with an age range of 70 91 d. Skin from AA-affected male and female mice was also grafted to 17 juvenile normal haired C3H/HeJ mice (eight female, nine male) aged 21 31 d. Using these mice with induced AA, a further study was done by grafting of induced AA-affected skin onto 10 more normal haired C3H/HeJ mice (two female, eight male), all 104 d old. Histocompatible mice The C3H/OuJ (C3H/HeOuJ) mouse strain is immunocompetent, has no prior history of AA-like hair loss in Jackson Laboratory production colonies, and C3H/OuJ mice are histocompatible (H- 2K haplotype) with C3H/HeJ mice. Full-thickness, AA-affected C3H/HeJ mouse skin was transferred to 13 C3H/OuJ mice (four female, nine male) with an age range of 63 84 d. Sham graft control mice Four C3H/OuJ (one female, three male) and six normal haired C3H/HeJ mice (four female, two male) had skin taken from their dorsal surface using the technique described above and then returned to the same mouse. Histologic analysis At the same time as grafting, skin from graft donors was taken immediately adjacent to excision sites on the dorsal surface on day 0. Skin removed from recipients prior to receiving donor skin was also collected and fixed for histologic analysis. Upon completion of each study, each mouse was euthanized by CO 2 asphyxiation and necropsied. Skin was collected across each graft, including adjacent host skin. Grafts were not taken during the study due to the hair wave induction effect of surgery and concern about complications due to scarring from wounding (Sundberg et al, 1997). Biopsies were fixed in Fekete s acid-alcohol-formalin solution and processed routinely for hematoxylin and eosin staining. Mice were examined weekly to evaluate healing and progression of disease. Dorsal, ventral, and flank macro photographs were taken using ISO400 slide film (Kodak, Rochester, NY) of each donor and recipient mouse under anesthetic on day 0 and of recipients at the completion of each study. RESULTS Several observations were common to all grafting studies. Graft contraction was frequently observed, particularly when graft recipients were normal haired mice and ventral skin contracted less than dorsal skin. Initial stimulation of host hair follicles adjacent to the graft site to progress from telogen into an anagen hair growth state was observed as expected (Sundberg et al, 1997). Anagen induction in adjacent recipient skin was an advantage in these studies because inflammatory cells only infiltrate anagen hair follicles in humans, Dundee experimental bald rats, and C3H/HeJ mice with AA (Perret et al, 1984; Sundberg et al, 1994b; Zhang and Oliver, 1994). The hair wave induction phenomenon also permitted comparison of adjacent donor and recipient hair follicles known to be in the same stage of hair growth. Immunodeficient mice Results of the various studies are summarized in Table I. Alopecic skin from AA-affected C3H/HeJ mice was grafted onto 15 recipient C3H scid/scid mice (Fig 1). All recipients readily accepted the grafts without complications and all mice had white hair regrowth in their AA-affected skin grafts (Fig 1C). First hair growth was noted in one mouse by day 28 and hair growth was apparent in all grafts by 42 d post-surgery. Hair typically first regrew from the periphery of the skin graft, with follicles at the center of the graft producing visible hair a few days later. Recipient C3H scid/scid hair follicles were not macroscopically affected for the duration of the study and no hair dystrophy was observed. Histology of donor skin at day 0 typically revealed a dense mononuclear cell infiltrate in and around dystrophic anagen hair follicles in all AA-affected C3H/HeJ donor mice. Catagen and telogen hair follicles had no associated inflammatory infiltrate. C3H scid/scid recipients typically showed no infiltrated telogen follicles and normal waves of anagen hair growth. On completion of the study, the histology of biopsy site confirmed that hair regrew around the periphery with some regrowth of isolated hair follicles toward the center of the grafts (Fig 2). Some isolated mononuclear cells were detected within the graft and infiltrating around adjacent anagen hair follicles of the recipient; however, the inflammatory cell infiltrate around graft hair follicles, and recipient C3H scid/scid anagen hair follicles, also included large numbers of neutrophils and eosinophils (Fig 2B). Occasional multinucleated giant cells were observed in peripheral scid/scid anagen hair follicles. Skin from normal haired C3H scid/scid mice was also grafted onto 18 adult AA-affected C3H/HeJ mice (Fig 3). All grafts were readily accepted by C3H/HeJ recipients. Hair loss within grafted skin was rapid, beginning 14 d post-surgery in one mouse. In other mice, hair was first lost from the periphery of the graft with gradual encroachment of hair follicle dystrophy toward the graft center between 14 and 21 d. All mice exhibited hair follicle dystrophy over the entire graft 35 d post-surgery (Fig 3C). There was no apparent hair regrowth or other macroscopic change in status of the grafts up to 70 d post-surgery. Histology of these sites revealed scarring associated with surgery and

VOL. 111, NO. 5 NOVEMBER 1998 T LYMPHOCYTE ASSOCIATION OF ACTIVATED HUMAN SKIN DENDRITIC CELLS 799 Table I. Summary of results from skin graft protocols Successful Hair Permanent Mean days Mean days Skin graft /total Hair loss loss in graft hair between surgery between surgery Skin graft donors recipients transplants in graft recipient regrowth and hair loss and hair growth AA-affected C3H/HeJ C3H/SmnC Prkdc scid /J 15/15 0 0 15 36.8 2.8 SD C3H/SmnC Prkdc scid /J AA-affected C3H/HeJ 18/18 18 18 0 21.5 9.7 SD Normal C3H/HeJ AA-affected C3H/HeJ 10/10 10 10 0 21.5 4.7 SD AA-affected C3H/HeJ Normal C3H/HeJ 15/18 15 15 0 63.3 5.6 SD 70 d old AA-affected C3H/HeJ Normal C3H/HeJ 17/17 4 4 13 68.8 9.4 SD 42.2 7.6 SD 31 d old Induced AA-affected Normal C3H/HeJ 9/10 9 9 0 60.0 9.3 SD C3H/HeJ 70 d old AA-affected C3H/HeJ Normal C3H/OuJ 10/13 4 4 6 56.5 10.5 SD 39.8 4.4 SD Normal C3H/HeJ Self, sham graft 10/10 0 0 10 20.8 3.4 SD or C3H/OuJ Figure 2. Histology of AA-affected C3H/HeJ skin grafts and C3H/ SmnC Prkdc scid /J graft recipients 80 d post-surgery. Transverse section with induced anagen host hair follicles (left) and graft with isolated follicles and scarring (right, A, scale bar: 100 µm). Infiltrate of neutrophils and eosinophils plus isolated mononuclear cells evident in boxed area (B, scale bar: 10 µm). Figure 1. AA-affected C3H/HeJ skin when transplanted to a C3H/ SmnC Prkdc scid /J mouse. (A) Day 0 immediately before surgery; (B) day 0 immediately after surgery; (C) 80 d post-surgery with white hair growth from the graft. the presence of a mononuclear cell infiltrate around dystrophic anagen hair follicles in the C3H scid/scid skin graft and in dorsal and ventral C3H/HeJ recipient skin (Fig 4). Immunocompetent mice Skin from young unaffected C3H/HeJ mice was grafted onto 10 AA-affected C3H/HeJ mice and all allografts survived the duration of the study. Hair loss was apparent within 21 d in all skin grafts and eventually all hair follicles within grafts were dystrophic after 35 d. As with C3H scid/scid skin grafted to AA-affected C3H/HeJ mice, hair at the periphery of grafts was lost first, hair in the center survived longer. Microscopically, a mononuclear cell infiltrate in and around anagen hair follicles within the graft was evident upon completion of the study, 70 d post-surgery. Skin from AA-affected C3H/HeJ mice grafted to normal adult C3H/HeJ mice consistently induced AA in all transplant recipients both at the graft site and also distal from the graft on the ventral and/ or dorsal surface (Fig 5). No difference in ability to induce AA was observed using dorsal or ventral, male or female, derived AA-affected skin grafts. Of 10 female and eight male normal grafted C3H/HeJ

800 McELWEE ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY Figure 4. Histology of C3H/SmnC Prkdc scid /J skin transplanted onto an AA-affected C3H/HeJ mouse. Transverse section with graft skin plus anagen hair follicles (left) and host skin containing anagen hair follicles (right, scale bar: 100 µm). C3H/SmnC Prkdc scid /J skin graft derived anagen hair follicles with a similar mononuclear cell infiltrate (B, scale bar: 10 µm). Host anagen hair follicles with nonscarring focal peri and intrafolliclular infiltrate of mononuclear cells (C, scale bar: 10 µm). Figure 3. C3H/SmnC Prkdc scid /J skin transplanted to an AA-affected C3H/HeJ mouse. (A) Day 0 immediately before surgery with extensive diffuse dorsal hair loss plus isolated patchy alopecia; (B) day 0 immediately after surgery with normal, haired C3H/SmnC Prkdc scid /J skin graft; (C) 80 d postsurgery with diffuse, aberrant hair fiber from the graft and diffuse, aberrant host hair proximal and distal to the graft site. adults, 15 developed patchy AA. The two female and one male mice that did not lose hair failed to accept their grafts. Graft rejection was clearly apparent within 7 d from transplantation surgery. Typical presentation of successful grafts involved some initial white hair regrowth from the AA-affected graft skin first seen 21 d after grafting. This hair growth was first observed around the periphery of the graft with the center becoming rehaired a few days later. Regrowth was short lived as hair was lost from all grafts by 49 d post-surgery. Hair loss developed in recipient mice by 77 d with the first observation of hair loss made in one mouse on day 53. The first evidence of hair loss was frequently noted as a narrow ring around the graft site, swiftly followed by ventral hair loss (Fig 5C, D). Dorsal hair loss distal to the graft site typically took longest to develop. Microscopically, grafted donor skin contained dystrophic anagen hair follicles associated with a peri- and intrafollicular mononuclear cell infiltrate (Fig 6). Recipients had typical anagen waves of hair growth and telogen hair follicles with no mononuclear cell involvement. Histologic tissue sections showed scarring associated with graft healing, isolated dystrophic hair follicles within the graft, and a mononuclear cell infiltrate. Host hair follicles immediately adjacent to the graft, and on the ventral surface, were dystrophic, and infiltrated with mononuclear cells when in anagen (Fig 6C), but when in catagen or telogen there was no inflammation. The distribution of inflammation was the same as observed for spontaneous AA. Intense peri-follicular lymphocyte inflammation was observed from the bulbs to sebaceous glands with greatest intensity of cells focusing on the infundibulum. As with some stages of spontaneous mouse AA, some individual anagen hair follicles of graft recipients adjacent to the graft site had peri-follicular inflammation that contained a number of granulocytes in addition to lymphocytes. Individual lymphocytes had penetrated to intrafollicular positions. In addition to grafting adult mice greater than 70 d of age, 17 juvenile C3H/HeJ mice up to 31 d of age were also grafted with AAaffected C3H/HeJ skin. Of eight female and nine male mice, four female mice developed extensive AA but no males had any signs of hair loss. Histologic features of skin from recipient males and grafts consisted primarily of telogen or anagen hair follicles with no inflammation or other abnormalities. All dorsal hair follicles were in telogen. Histologic features of AA-affected females included the classic type of mononuclear cell infiltrate seen in AA, similar to the presentation of spontaneous adult AA-affected mouse skin described above. The four juvenile female mice with induced AA were then used as skin graft donors for additional normal haired, adult C3H/HeJ mice. These skin grafts were equally capable of inducing AA in the naïve hosts. Of two female and eight male normal haired, grafted mice, hair loss was first observed in one mouse 49 d after grafting, and nine of 10 total mice were affected with patchy hair loss by 70 d. One male mouse failed to develop hair loss as the graft was rejected by 7 d postsurgery. Some mice first exhibited hair loss within the graft and in a ring of host skin adjacent to the graft. Hair loss was first observed distal to the graft site on the ventral surface, presenting as one or more symmetrically aligned patches of dystrophic hair follicles. Dorsal skin

VOL. 111, NO. 5 NOVEMBER 1998 T LYMPHOCYTE ASSOCIATION OF ACTIVATED HUMAN SKIN DENDRITIC CELLS 801 Figure 6. Histology of AA-affected C3H/HeJ skin grafted to a normal, haired C3H/HeJ mouse 90 d post-surgery. Transverse section with graft including isolated hair follicles and scar tissue (left) and recipient skin containing hair follicles induced by surgery into anagen (right, A, scale bar: 100 µm). Inflammatory cell infiltrate around graft anagen hair follicles (B, scale bar: 10 µm). Recipient anagen hair follicles associated with a peri and intra bulbar mononuclear cell infiltrate (C, scale bar: 10 µm). Figure 5. AA-affected C3H/HeJ skin grafted to a normal, haired C3H/ HeJ mouse. (A) On day 0 immediately before surgery; (B) on day 0 immediately after surgery; (C) 90 d post-surgery with minimal apparent hair growth from the skin graft, localized hair loss around the graft, and onset of AA in graft recipient distal to the graft site; (D) symmetrical AA in the graft recipient on the ventral surface. distant or far removed from the graft site gradually became affected with patchy hair loss, first observed at 84 d post-surgery. Histocompatible mice AA-affected C3H/HeJ mouse skin was transferred to four female and nine male C3H/OuJ mice. Three of 13 mice rejected their grafts by 7 d post-surgery but hair loss was successfully induced in four mice. Hair loss was first observed in two female mice 49 and 63 d after surgery. Patchy hair loss first presented on the ventral surface, later progressing to the dorsum similar to progression of spontaneous AA observed in C3H/HeJ mice. It took 70 d before any host hair loss was apparent from male C3H/OuJ mice. Two males developed patchy hair loss by 84 d. Male C3H/OuJ mice that remained unaffected had white hair regrowth within their skin grafts. Histology of C3H/OuJ mice with graft hair regrowth and no hair loss showed no signs of follicular inflammation. Mice with hair loss had a peri- and intra follicular mononuclear cell infiltrate in both graft and host skin typical of mouse AA. Sham graft control mice Sham grafting in three male and one female immunocompetent C3H/OuJ mice, or four female and two male normal haired adult C3H/HeJ mice, did not induce AA. No sham grafted mice revealed any untoward phenomena. Hair fibers growing from sham autografts were normal, pigmented agouti hair. In contrast, all hair growth in allograft studies was always depigmented. Scarring from surgery was observed with no inflammatory cell infiltrate in the skin. The seven mice that rejected their grafts in the other studies (three C3H/OuJ and four C3H/HeJ mice) might also be interpreted as a form of negative control. No hair loss was observed in any mouse that had previously rejected its skin graft. DISCUSSION Immunodeficient mice Examination of the immunodeficient mouse response to AA-affected skin grafts is important in understanding the roles of lymphocyte activation in AA pathogenesis. Lesional skin biopsies from humans or rats are capable of regrowing hair when transplanted onto immunodeficient animals (Gilhar and Kreuger, 1987; Gilhar et al, 1992, 1998; Oliver, University of Dundee, Dundee, Scotland, personal communication). The grafting of AA-affected C3H/ HeJ mouse skin to immunocompromised C3H scid/scid mice resulted in white hair regrowth in the grafted skin. This hair regrowth suggests AA-affected hair follicles (i) are in a dystrophic anagen or telogen state, (ii) are not permanently destroyed, and (iii) may regrow hair. From the results it seems AA is a reversible non-scarring disease in C3H/ HeJ mice, although discrete limited scarring can be associated with follicular inflammation in C57BL/6 mice (Eichmüller et al, 1998).

802 McELWEE ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY Microscopically, the C3H scid/scid recipient mice response to grafting consisted of a dense infiltration of neutrophils and eosinophils around anagen hair follicles in the C3H scid/scid skin adjacent to the AAaffected graft. There was no overt hair loss but a C3H scid/scid compromised immune system will attempt to respond to the graft activation factor(s) in AA-affected C3H/HeJ mouse skin. Failure to induce actual hair loss in C3H scid/scid mice suggests that an immune system, activated by histocompatible grafts, is incapable of inducing hair loss without the presence of T and/or B lymphocytes and their products. Conversely, hair regrowth in AA-affected grafts onto C3H scid/scid recipients shows normal function in the absence of B and/or T inflammatory cell activity. Lack of hair loss in C3H scid/scid mice suggests an induced viral form of AA is very unlikely in mice. The skin graft technique effectively inoculates recipient mice with any infectious agents that may reside in AA-affected C3H/HeJ mouse skin; however, the studies do not rule out the possibility of an abnormal hair follicle function or local pathogen infection inducing secondary inflammation that leads to overt hair loss. Cytomegalovirus has been suggested in association with AA in humans (Skinner et al, 1995a, b), but C3H/HeJ mice consistently tested negative for murine cytomegalovirus DNA or antibodies against this virus (Sundberg et al, 1994b; McElwee et al, 1998a). More than 30 different mouse strains are housed in close proximity within the same breeding room under the same conditions. Of these, only C3H/ HeJ mice spontaneously develop AA. Normal haired C3H scid/scid or C3H/HeJ skin when grafted to AA-affected C3H/HeJ mice became infiltrated with mixed, primarily mononuclear inflammatory cells and hair loss developed. Hair loss from normal haired grafts suggests an immune system, exposed to dystrophic hair follicles, is fully capable of responding to anagen hair follicles not previously affected by AA. That the skin grafts rapidly conform to the systemic state of the recipients also infers that the regulation of AA hair loss lies with the immune system as opposed to development of hair follicle abnormalities. Hair follicles are regarded as an immunologically privileged site (Barker and Billingham, 1977; Westgate et al, 1991). Several hypotheses for alopecia areata onset are based on the loss of hair follicle immune privilege through upregulation of MHC class I and class II expression in normally negative hair bulbs with exposure of previously sequestered antigens to autoreactive T cells (Paus et al, 1994). In C3H/HeJ mice the purported immune privilege of hair follicles breaks down quickly with little resistance to the pathogenic mechanisms of AA. Overt hair loss developed in normal haired grafts on alopecia recipients within 28 d of surgery. Immunocompetent mice The spontaneous expression rate of AA is 0.25% for C3H/HeJ mice aged 5 mo, and rises to 20% for mice aged 18 mo (Sundberg et al, 1994b); however, induction of AA by skin grafting suggests 100% of C3H/HeJ mice greater than 70 d old are susceptible to hair loss. It is possible that some humans have similar genetic susceptibility to AA but require an event to trigger hair loss. The requirement for several different factors to collectively contribute to AA has previously been suggested (Paus et al, 1994). In support of AA being an autoimmune cell-mediated disease, AAlike hair loss has been induced using other mouse models. AA-affected human skin grafted to a Prkdc scid mouse model regrows hair. In vitro stimulated T cells derived from AA-affected skin injected into such grafts on Prkdc scid mutant mice induces hair loss (Gilhar et al, 1998). Lymphocyte-mediated hair loss has also apparently been induced in C57BL6/J mice after immunotherapy for melanoma (Becker et al, 1996). Passive transfer of T cells, specifically CD8 cells, to naïve mice transferred the alopecia phenotype; however, any suggestion of inflammatory alopecia induction in C57BL6/J mice must be tempered by the knowledge that this strain is predisposed to barbering and alopecia through ulcerative, inflammatory dermatitis (Militzer and Wecker, 1986; Sundberg et al, 1994a) that is believed to be based on an autoimmune mechanism (Andrews et al, 1994). Grafts of skin from AA-affected C3H/HeJ mice placed on unaffected C3H/HeJ hosts induced hair loss. The association of hair loss with predominantly lymphocytic inflammation would circumstantially support immune mediation of AA. AA-affected mouse skin may contain factors capable of activating hair loss in immunocompetent hosts by promoting host-derived mononuclear cells and triggering an immune response against hair follicles in the grafted skin and host hair follicles. Most likely activated lymphocytes and/or antigen-presenting cells are transferred with the skin graft and prime naïve host lymphocytes. Failure of AA-affected C3H/HeJ skin grafts to induce AA in C3H scid/scid mice suggests that hair loss in immunocompetent C3H/HeJ, and C3H/OuJ, mice is not due to passive transfer of inflammatory cells and/or autoantibodies within AA-affected skin grafts. If AA was transferred, as opposed to actively induced by full-thickness skin grafts, hair loss would be expected to occur in C3H scid/scid recipients of AA-affected C3H/HeJ skin. It was also possible to induce AA by grafting AA-affected skin to C3H/HeJ female mice as young as 21 d of age; however, male, and to a lesser degree female, juvenile C3H/HeJ mice were more resistant to development of AA by graft induction. Only 30% of the grafted juvenile mice developed AA. Apparently an immature mouse is less susceptible to activation and mediation of an attack on hair follicles leading to AA. Maturation of the skin, hair cycles, hair structure, and/ or immune system may be important in determining susceptibility to AA. Histocompatible mice It is particularly interesting that skin grafts from AA-affected C3H/HeJ mice had the ability to induce nonscarring, inflammatory hair loss in C3H/OuJ mice. C3H/OuJ mice were derived from C3H/HeJ mice in advance of the apparent onset of the AA phenotype in the C3H/HeJ mouse production colony at The Jackson Laboratory (Sundberg et al, 1994b). C3H/OuJ mice differ in their genetic composition, notably C3H/OuJ mice are lipopolysaccharide susceptible whereas C3H/HeJ mice are lipopolysaccharide resistant (Doolittle et al, 1996) The ability to induce AA in the histocompatible C3H/OuJ strain that is not prone to spontaneous AA-like hair loss suggests that an individual with no apparent inherited history of hair loss can develop AA if given a strong trigger factor. These results suggest that the immune system is the regulatory factor in AA rather than hair follicle defects, although we cannot rule out the possibility that the hair follicles from C3H mice are different from hair follicles in other entirely unrelated strains. C3H/HeJ mice will continue to be invaluable in the investigation of AA as skin graft induction of AA can be employed in the analysis of disease pathogenesis. Taken together, our studies support the notion that AA hair loss is mediated by the immune system and that AA can be actively induced in an immunocompetent mouse using appropriate stimuli. Affected AA skin from donor females successfully grafted onto normal, haired C3H/HeJ females at 70 d of age yields onset of AA in 100% of recipients. The data also document the age and sex dependence of susceptibility towards AA, where induction of AA in mice less than 31 d old was more variable. The skin graft technique will allow studies on the influence of gender and the nature of the maturation required before an individual is predisposed to development of AA. The consistent induction of AA in adult C3H/HeJ mice provides a rapid, reliable evaluation model to examine the systemic and local pathogenic events taking place from trigger factor to onset of AA hair loss. The technique makes prospective studies possible with even greater consistency and precision than previously possible. The ability to transfer previously induced AA from one C3H/HeJ mouse to another and perpetuate the hair loss will be of considerable practical use in producing large numbers of AA-affected mice for use in treatment development. The authors gratefully acknowledge Dr. J-C. Bystryn, New York University, for discussion and critical reading of this manuscript, and P. Jewett and J. Martin, The Jackson Laboratory, for histologic and surgical services, respectively. This work was supported in part by research grants from the National Alopecia Areata Foundation (JPS, LEK), National Institutes of Health (AR43801, JPS), National Cancer Institute (CA34196, JPS), Glaxo Dermatology/Dermatology Foundation (KJM), and funds from the Department of Veterans affairs (LEK).

VOL. 111, NO. 5 NOVEMBER 1998 T LYMPHOCYTE ASSOCIATION OF ACTIVATED HUMAN SKIN DENDRITIC CELLS 803 REFERENCES Andrews AG, Dysko RC, Spilman SC, Kunkel RG, Brammer DW, Johnson KJ: Immune complex vasculitis with secondary ulcerative dermatitis in aged C57BL/NNia Mice. Vet Pathol 31:293 300, 1994 Barker CF, Billingham RE: Immunologically privileged sites. Adv Immunol 25:1 54, 1977 Becker JC, Varki N, Brocker EB, Reisfeld RA: Lymphocyte mediated alopecia in C57BL/ 6 mice following successful immunotherapy for melanoma. J Invest Dermatol 107:627 632, 1996 Billingham RE, Medawar PB: The technique of free skin grafting in mammals. J Exp Biol 28:385 405, 1951 Colon EA, Popkin MK, Callies AL, Dessert NJ, Hordinsky MK: Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 32:245 251, 1991 Doolittle DP, Davisson MT, Guidi JN, Green MC: Catalog of mutant genes and polymorphic loci. In: Lyon MF, Rastan S, Brown SDM (eds). Genetic Variants and Strains of the Laboratory Mouse, 3rd edn, Vol 1. New York: Oxford University Press, 1996, pp. 17 854 Eichmüller S, van der Veen C, Moll I, Hermes B, Hofmann U, Müller-Röver S, Paus R: Clusters of perifollicular macrophages in normal murine skin: Physiological degeneration of selected hair follicles by programmed organ deletion. Histochem Cytochem 46:361 370, 1998 Gijbels MJ, HogenEsch H, Bruijnzeel PL, Elliott GR, Zurcher C: Maintenance of donor phenotype after full-thickness skin transplantation from mice with chronic proliferative dermatitis (cpdm/cpdm) to C57BL/Ka and nude mice and vice versa. J Invest Dermatol 105:769 773, 1995 Gilhar A, Kreuger GG: Hair growth in scalp grafts from patients with alopecia areata and alopecia universalis grafted onto nude mice. Arch Dermatol 123:44 50, 1987 Gilhar A, Pillar T, Assay B, David M: Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice. Br J Dermatol 126:166 171, 1992 Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS: Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 101:62 67, 1998 Haftek M, Ortonne J-P, Staquet M-F, Viac J, Thivolet J: Normal and psoriatic human skin grafts on nude mice: morphological and immunochemical studies. J Invest Dermatol 76:48 52, 1981 Kreuger GG, Manning DD, Malouf J, Ogden B: Long-term maintenance of psoriatic human skin on congenitally athymic (nude) mice. J Invest Dermatol 64:307 312, 1975 Kreuger GG, Chambers DA, Shelby J: Involved and uninvolved skin from psoriatic subjects: are they equally diseased? Assessment by skin transplanted to congenitally athymic (nude) mice. J Clin Invest 68:1548 1557, 1981 McElwee KJ, Oliver RF: Animal model of human disease: alopecia areata. Comparative Pathology Bulletin 29:4 5, 1997 McElwee KJ, Pickett P, Oliver RF: The DEBR rat, alopecia areata and autoantibodies to the hair follicle. Br J Dermatol 134:55 62, 1996 McElwee KJ, Boggess D, Burgett B, Bates R, Bedigan HG, King LE Jr, Sundberg JP: Murine cytomegalovirus is not associated with alopecia areata in C3H/HeJ mice. J Invest Dermatol 110:986 987, 1998a McElwee KJ, Boggess B, Olivry T, et al: Comparison of alopecia areata in human and non-human mammalian species. Pathobiology 66:90 107, 1998b Michie HJ, Jahoda CAB, Oliver RF, Johnson BE: The DEBR rat: an animal model of human alopecia areata. Br J Dermatol 125:94 100, 1991 Militzer K, Wecker E: Behavior associated alopecia areata in mice. Lab Anim 20:9 13, 1986 Nonoyama S, Smith FO, Bernstein ID, Ochs HD: Strain-dependent leakiness of mice with severe combined immune deficiency. J Immunol 150:3817 3824, 1993 Oliver RF, Jahoda CAB, Horne KA, Michie HJ, Poulton T, Johnson BE: The DEBR rat model for alopecia areata. J Invest Dermatol 96 (Suppl):97s, 1991 Paus R, Slominski A, Czarnetzki BM: Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med 66:541 554, 1994 Perret C, Weisner-Menzel L, Happle R: Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm Venerol 64:26 30, 1984 Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd: Incidence of alopecia areata in Olmsted County, Minnesota 1975 through 1989. Mayo Clin Proc 70:628 633, 1995 Shultz LD, Schweitzer PA, Hall EJ, Sundberg JP, Taylor S, Walzer PD: Pneumocystis carinii pneumonia in scid/scid mice. Current Topics Microbiol Immunol 152:243 249, 1989 Skinner RB Jr, Light WH, Leonardi C, Bale GF, Rosenberg EW: A molecular approach to alopecia areata. J Invest Dermatol 104 (Suppl):3s 4s, 1995a Skinner RB Jr, Light WH, Bale GF, Rosenberg EW, Leonardi C: Alopecia areata and presence of cytomegalovirus DNA. JAMA 273:1419 1420, 1995b Sundberg JP, Brown KS, McMahon WM: Chronic ulcerative dermatitis in black mice. In: Sundberg JP (eds). Handbook of Mouse Mutations with Skin and Hair Abnormalities: Animal Models and Biomedical Tools. Boca Raton: CRC Press, 1994a, pp. 485 492 Sundberg JP, Cordy WR, King LE Jr: Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 102:847 856, 1994b Sundberg JP, Dunstan RW, Roop DR, Beamer WG: Full-thickness skin grafts from flaky skin mice to nude mice: maintenance of the psoriasiform phenotype. J Invest Dermatol 102:781 788, 1994c Sundberg JP, Oliver RF, McElwee KJ, King LE Jr: Alopecia areata in humans and other mammalian species. J Invest Dermatol 104 (Suppl):32s 33s, 1995 Sundberg JP, Rourk MH, Boggess D, Hogan ME, Sundberg BA, Bertolino AP: Angora mouse mutation: altered hair cycle, follicular dystrophy, phenotypic maintenance of skin grafts, and changes in keratin expression. Vet Pathol 34:171 179, 1997 Tobin DJ, Orentreich N, Fenton DA, Bystryn J-C: Antibodies to hair follicles in alopecia areata. J Invest Dermatol 102:721 724, 1994 Tobin DJ, Sundberg JP, King LE Jr, Boggess D, Bystryn J-C: autoantibodies to hair follicles in the C3H/HeJ mouse model of alopecia areata. J Invest Dermatol 109:329 333, 1997 Westgate GE, Craggs RI, Gibson WT: Immune privilege in hair growth. J Invest Dermatol 97:417 420, 1991 Zhang JG, Oliver RF: Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata. Br J Dermatol 130:405 414, 1994